Clinical Trial Update: A Study to Assess Adverse Events and Change of Masseter Muscle Prominence Using BOTOX Injections in Adult Participants [Phase 3]

View source ↗

Summary

Phase 3 study assessing adverse events and changes in masseter muscle prominence after Botox injections in adults has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Masseter Muscle Prominence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: AbbVie | Conditions: Masseter Muscle Prominence | Phase 3 | Status: COMPLETED